.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Daiichi Sankyo
Teva
AstraZeneca
US Department of Justice
Chubb
Colorcon
Federal Trade Commission
Argus Health
US Army

Generated: June 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 062759

« Back to Dashboard
NDA 062759 describes ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL, which is a drug marketed by Barr and is included in one NDA. It is available from two suppliers. Additional details are available on the ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL profile page.

The generic ingredient in ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL is erythromycin ethylsuccinate; sulfisoxazole acetyl. There are ninety-eight drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate; sulfisoxazole acetyl profile page.

Summary for NDA: 062759

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 062759

Suppliers and Packaging for NDA: 062759

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL
erythromycin ethylsuccinate; sulfisoxazole acetyl
GRANULE;ORAL 062759 ANDA Rebel Distributors Corp 21695-690 21695-690-00 100 mL in 1 BOTTLE (21695-690-00)
ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL
erythromycin ethylsuccinate; sulfisoxazole acetyl
GRANULE;ORAL 062759 ANDA Physicians Total Care, Inc. 54868-0971 54868-0971-1 100 mL in 1 BOTTLE (54868-0971-1)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:GRANULE;ORALStrengthEQ 200MG BASE/5ML;EQ 600MG BASE/5ML
Approval Date:May 20, 1988TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Medtronic
Colorcon
Johnson and Johnson
QuintilesIMS
Express Scripts
Teva
Cantor Fitzgerald
Fish and Richardson
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot